DSM-Firmenich AG (DSFIY)

OTCMKTS · Delayed Price · Currency is USD
10.46
+0.04 (0.38%)
Apr 23, 2025, 4:00 PM EDT
-7.19%
Market Cap 27.65B
Revenue (ttm) 13.25B
Net Income (ttm) 258.83M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 106.83
Forward PE n/a
Dividend 0.22 (2.14%)
Ex-Dividend Date May 9, 2024
Volume 8,797
Average Volume 132,778
Open 10.48
Previous Close 10.42
Day's Range 10.36 - 10.52
52-Week Range 8.86 - 13.98
Beta 1.03
RSI 57.80
Earnings Date Jul 31, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Sector Materials
Founded 1902
Employees 26,301
Stock Exchange OTCMKTS
Ticker Symbol DSFIY
Full Company Profile

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR Financial Statements

News

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

Press Release Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025 dsm-firmenich, innovators in nutrit...

16 days ago - GlobeNewsWire

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre Pectin to 90.5% Kaiseraugst (Switzerland), Maastricht (Netherlands), April 3, 2025 dsm-firmenich, innovators in nutrition, health, ...

21 days ago - GlobeNewsWire

Human Milk Oligosaccharides (HMOs) Market Insights 2025, Analysis and Forecast to 2030 Featuring Key Companies - DSM-Firmenich, Kyowa Hakko, and Chr. Hansen

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Human Milk Oligosaccharides (HMOs) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Produ...

4 weeks ago - GlobeNewsWire

dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

Press Release dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day Kaiseraugst (Switzerland), Maastricht (Netherlands), March 25, 2025 ...

4 weeks ago - GlobeNewsWire

DSM-Firmenich: Improving Fundamentals At A More Digestible Valuation

DSM-Firmenich's FY 2024 results show promising growth and profitability, with 6% organic sales growth and 19% adjusted EBITDA increase, despite a challenging macroeconomic environment. The company is ...

7 weeks ago - Seeking Alpha

dsm-firmenich publishes 2024 Integrated Annual Report

Press Release dsm-firmenich publishes 2024 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 28, 2025 dsm-firmenich today announces the publication of its 2024 Int...

7 weeks ago - GlobeNewsWire

dsm-firmenich issues €750 million long-term bond

Press Release dsm-firmenich issues €750 million long-term bond Kaiseraugst (Switzerland), Maastricht (Netherlands), February 19, 2025 dsm-firmenich today announces the successful launch of a €750 mill...

2 months ago - GlobeNewsWire

DSM-Firmenich is a smarter, faster working engine post merger, says CEO

Dimitri De Vreeze, CEO of Dsm-Firmenich, talks about the company's merger and share buyback program off the back of its full-year earning results.

2 months ago - CNBC International TV

DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ral...

6 months ago - Seeking Alpha

dsm-firmenich to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on September 25 2024

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors,...

7 months ago - GlobeNewsWire

DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...

9 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...

1 year ago - Seeking Alpha